We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Endothelial expression of fractalkine (CX3CL1) is induced by Toll-like receptor 3 signaling in cultured human glomerular endothelial cells.
- Authors
Koji Hirono; Tadaatsu Imaizumi; Tomomi Aizawa; Shojiro Watanabe; Koji Tsugawa; Toshihiro Shiratori; Shogo Kawaguchi; Kazuhiko Seya; Tomoh Matsumiya; Etsuro Ito; Hiroshi Tanaka
- Abstract
Background: Endothelial expression of membrane-bound fractalkine/CX3CL1 (Fkn) reportedly acts as a strong mediator of inflammation. Toll-like receptor 3 (TLR3) axes are thought to play some roles in the development of chronic glomerulonephritis (CGN) including lupus nephritis (LN). However, detailed mechanism of TLR3-mediated Fkn expression in glomerular endothelial cells (GECs) remains to be elucidated.Methods: We examined the effect of polyinosinic-polycytidylic acid (poly IC) on Fkn expression in cultured human GECs. Fkn mRNA and protein levels were quantified by real-time PCR and enzyme-linked immunosorbent assay, respectively. To further elucidate the effects of poly IC on this signaling pathway, we used small-interfering RNA (siRNA) to knockdown expression of TLR3, nuclear factor (NF)-κB p65, interferon (IFN)-β, and IFN regulatory factor 3 (IRF3). We then analyzed whether pretreatment of chloroquine or dexamethasone (DEX) inhibits poly IC-induced Fkn expression.Results: We found that poly IC-induced Fkn expression in GECs, and that this involved NF-κB, IFN-β, and IRF3. Pretreating cells with chloroquine, but not DEX attenuated poly IC-induced Fkn expression in GECs.Conclusion: Since the activation of TLR3/NF-κB/IFN-β/Fkn and TLR3/IRF3/Fkn axes is involved in inflammatory reactions in GECs, intervention of glomerular TLR3 signaling may be a suitable therapeutic strategy for treating CGN especially LN.
- Subjects
FRACTALKINE; INFLAMMATION; TOLL-like receptors; GLOMERULONEPHRITIS; LUPUS nephritis
- Publication
Modern Rheumatology, 2020, Vol 30, Issue 6, p1074
- ISSN
1439-7595
- Publication type
Article
- DOI
10.1080/14397595.2019.1682768